CSL EL SALVADOR HUMAN COAGULATION FACTOR VIII FOR INJECTION 250IU Australia - English - Department of Health (Therapeutic Goods Administration)

csl el salvador human coagulation factor viii for injection 250iu

csl behring australia pty ltd - factor viii, quantity: 250 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL ECUADOR HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Australia - English - Department of Health (Therapeutic Goods Administration)

csl ecuador human coagulation factor viii for injection 500iu

csl behring australia pty ltd - factor viii, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL PANAMA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Australia - English - Department of Health (Therapeutic Goods Administration)

csl panama human coagulation factor viii for injection 500iu

csl behring australia pty ltd - factor viii, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

CSL COLOMBIA HUMAN COAGULATION FACTOR VIII FOR INJECTION 500IU Australia - English - Department of Health (Therapeutic Goods Administration)

csl colombia human coagulation factor viii for injection 500iu

csl behring australia pty ltd - factor viii, quantity: 500 iu - injection, solution - excipient ingredients: water for injections - human coagulation factor viii is indicated for the treatment and prophylaxis of bleeding associated with factor viii deficiency due to haemophilia a.

Octanate 50IU/ml powder and solvent for solution for injection  (5ml vial) Malta - English - Medicines Authority

octanate 50iu/ml powder and solvent for solution for injection (5ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - factor viii, human - powder and solvent for solution for injection - factor viii, human 50 iu/ml - antihemorrhagics

Octanate 100IU/ml powder and solvent for solution for injection Malta - English - Medicines Authority

octanate 100iu/ml powder and solvent for solution for injection

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics

Octanate LV Pdr+Solv for Soln for Inj 100IU/ml Malta - English - Medicines Authority

octanate lv pdr+solv for soln for inj 100iu/ml

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - factor viii, human - powder and solvent for solution for injection - factor viii, human 100 iu/ml - antihemorrhagics

Octanate LV Pdr+Solv for Soln for Inj 200IU/ml Malta - English - Medicines Authority

octanate lv pdr+solv for soln for inj 200iu/ml

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - factor viii, human - powder and solvent for solution for injection - factor viii, human 200 iu/ml - antihemorrhagics

Octanate 50IU/ml powder and solvent for solution for injection  (10ml vial) Malta - English - Medicines Authority

octanate 50iu/ml powder and solvent for solution for injection (10ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - factor viii, human - powder and solvent for solution for injection - factor viii, human 50 iu - antihemorrhagics

WILATE  1000 Israel - English - Ministry of Health

wilate 1000

dover medical & scientific equipment ltd, israel - factor viii (human); von willebrand factor - powder and solvent for solution for injection - von willebrand factor 1000 iu/vial; factor viii (human) 1000 iu/vial - coagulation factor viii - von willebrand disease (vwd) :prevention and treatment of haemorrhage or surgical bleeding in von willebrand disease (vwd), when desmopressin (ddavp) treatment alone is ineffective or contra-indicated.haemophilia a :treatment and prophylaxis of bleeding in patients with haemophilia a (congenital fviii deficiency).